BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference (New York, NY) – September 4, 2024.2024 Wells Fargo Healthcare Conference (Boston, MA) – Markus Warmuth, M.D., Chief Executive Officer, to participate in a fireside chat, September 5, 2024, at 2:15 p.m. ET. A webcast of the fireside chat will be accessible via the "Events & Presentations" section of Monte Rosa's website at ir.monterosatx.com, and an archived v